James Paul Scopa insider trades
Open-market stock purchases and sales by James Paul Scopa, Unknown at Aligos Therapeutics, Inc, from SEC Form 4 filings since Jul 30, 2013.
Track record: 50% of 4 scored buys are up 5% or more since purchase, averaging +39%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 25, 2026 | ALGS Aligos Therapeutics, Inc | Bought (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $302K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $603K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $769K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $77K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $24.2K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $62.4K |
Companies traded
- ALGS Aligos Therapeutics, Inc: other filings, last Jun 25, 2026
- ADVM Adverum Biotechnologies, Inc: 3 buys, 1 sale, last Dec 9, 2025
- DICE DICE Therapeutics, Inc: 1 buy, 1 sale, last Aug 9, 2023
- CNAT Conatus Pharmaceuticals Inc: 1 buy, last Jun 21, 2018
- TRIV TriVascular Technologies, Inc: other filings, last Feb 3, 2016